On October 24, TransDigm fell 3.89% in Regular Trading, trading at $1099.06 per share, with turnover of $194 million.
The move coincided with a fresh round of analyst target-price reductions that pressured near-term sentiment. Morgan Stanley lowered its target to $1,300 from $1,400 on October 16, after RBC cut its target to $1,200 from $1,350 on October 15 while maintaining a sector perform rating, and Baird had already reduced its target to $1,100 from $1,400 on October 9.
While the broader analyst consensus still indicates an overweight view and the mean price target remains about $1,415.61, the recent clustering of lower targets points to a more cautious stance on TransDigm’s valuation upside in the near term. That softer tone appears to have outweighed support from the company’s earlier acquisition activity, including the completed $1.07 billion Prince & Izant deal announced in late September.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments